Reflections on the mechanism of MN-166 Medic Inova reported in the Proceedings of the National Academy of Sciences

Insight on MediciNova’s MN-166 Mechanism of Action Reported in Proceedings of the National Academy of Sciences
SAN DIEGO — MediciNova Inc, a biopharmaceutical company publicly traded on the NASDAQ Global Market and the Hercules Market of the Osaka Securities Exchange , today reported that the June 22, 2010 issue of Proceedings of the National Academy of Sciences USA included an article related to the mechanism of action of MN-166 , as an emerging therapeutic for neurological disorders.

This entry was posted by admin on July 11, 2010 at 4:59 pm, and is filed under Health Conditions. Follow any responses to this post through RSS 2.0.You can leave a response or trackback from your own site.

Sun	Mon	Tue	Wed	Thu	Fri	Sat
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

Reflections on the mechanism of MN-166 Medic Inova reported in the Proceedings of the National Academy of Sciences

CONTACT US

July 2010

Reflections on the mechanism of MN-166 Medic Inova reported in the Proceedings of the National Academy of Sciences

CONTACT US

July 2010

Log in